Specific humoral response of hosts with variable schistosomiasis susceptibility

Immunology and Cell Biology

Volumn 94, Issue 1, 2016, Pages 52-65

  Driguez, Patrick ^a   Mcwilliam, Hamish E G ^b   Gaze, Soraya ^c,d   Piedrafita, David ^e   Pearson, Mark S ^c   Nakajima, Rie ^f   Duke, Mary ^a   Trieu, Angela ^a   Doolan, Denise L ^a   Cardoso, Fernanda C ^a,g   Jasinskas, Algis ^f   Gobert, Geoffrey N ^a   Felgner, Philip L ^f   Loukas, Alex ^c   Meeusen, Els ^h   McManus, Donald P ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c JAMES COOK UNIVERSITY   (Australia)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e UNIVERSITY OF BALLARAT   (Australia)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HELMINTH ANTIBODY; HELMINTH PROTEIN; PARASITE ANTIGEN; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY SECRETING CELL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL INFECTION; LUNG; LYMPH NODE; MOUSE; NONHUMAN; PARASITE CLEARANCE; PARASITE MIGRATION; PROTEIN MICROARRAY; RAT; SCHISTOSOMA; SCHISTOSOMIASIS JAPONICA; SEROLOGY; SKIN; ANIMAL; HOST PATHOGEN INTERACTION; HUMORAL IMMUNITY; IMMUNOLOGY; PARASITE; PARASITOLOGY; RECEIVER OPERATING CHARACTERISTIC; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; WISTAR RAT;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; DISEASE SUSCEPTIBILITY; HOST-PATHOGEN INTERACTIONS; IMMUNITY, HUMORAL; MICE; PARASITES; PROTEIN ARRAY ANALYSIS; RATS, WISTAR; ROC CURVE; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; VACCINES;

EID: 84983127199     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2015.61     Document Type: Article

References (88)

1. Hotez PJ, Alvarado M, Basáñez M-G, Bolliger I, Bourne R, Boussinesq M et al. The Global Burden of Disease Study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis 2014; 8e2865.
2. Bergquist R, Al-Sherbiny M, Barakat R, Olds R. Blueprint for schistosomiasis vaccine development. Acta Trop 2002; 82: 183-192.
3. McManus DP. Prospects for development of a transmission blocking vaccine against Schistosoma japonicum. Parasite Immunol 2005; 27: 297-308.
4. Colley DG, Secor WE. Immunology of human schistosomiasis. Parasite Immunol 2014; 36: 347-357.
5. Stothard JR, Kabatereine NB, Tukahebwa EM, Kazibwe F, Rollinson D, Mathieson W et al. Use of circulating cathodic antigen (CCA) dipsticks for detection of intestinal and urinary schistosomiasis. Acta Trop 2006; 97: 219-228.
6. Lei JH, Su BT, Xu H, Shen JL, Guan XH, Feng ZQ et al. Evaluation of an IgY-based immunomagnetic enzyme-linked immunosorbent assay system for detection of circulating Schistosoma japonicum antigen in serum samples from patients in China. Am J Trop Med Hyg 2011; 85: 1054-1059.
7. He YX, Salafsky B, Ramaswamy K. Host-parasite relationships of Schistosoma japonicum in mammalian hosts. Trends Parasitol 2001; 17: 320-324.
8. Hu Y, Lu W, Shen Y, Xu Y, Yuan Z, Zhang C et al. Immune changes of Schistosoma japonicum infections in various rodent disease models. Exp Parasitol 2012; 131: 180-189.
9. Capron M, Capron A. Rats, mice and men-models for immune effector mechanisms against schistosomiasis. Parasitol Today 1986; 2: 69-75.
10. Sepulveda J, Tremblay JM, DeGnore JP, Skelly PJ, Shoemaker CB. Schistosoma mansoni host-exposed surface antigens characterized by sera and recombinant antibodies from schistosomiasis-resistant rats. Int J Parasitol 2010; 40: 1407-1417.
11. Khalife J, Cetre C, Pierrot C, Capron M. Mechanisms of resistance to S. mansoni infection: the rat model. Parasitol Int 2000; 49: 339-345.
12. Riveau G, Deplanque D, Remoue F, Schacht AM, Vodougnon H, Capron M et al. Safety and immunogenicity of rSh28GST antigen in humans: phase randomized clinical study of a vaccine candidate against urinary schistosomiasis. PLoS Negl Trop Dis 2012; 6: e1704.
13. Hotez PJ, Bethony JM, Diemert DJ, Pearson M, Loukas A. Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat Rev Microbiol 2010; 8: 814-826.
14. Dunne D, Mountford AP Resistance to infection in humans and animal models In: Mahmoud AA (ed). Schistosomiasis. Imerial College Press: London. 2001 pp 133-212.
15. Kigoni EP, Elsas PP, Lenzi HL, Dessein AJ. IgE antibody and resistance to infection. II. Effect of IgE suppression on the early and late skin reaction and resistance of rats to Schistosoma mansoni infection. Eur J Immunol 1986; 16: 589-595.
16. Dean DA, Mangold BL, Kassim OO, Von Lichtenberg F. Sites and mechanisms of schistosome elimination. Mem Inst Oswaldo Cruz 1987; 82 (Suppl 4): 31-37.
17. Ward RE, McLaren DJ. Schistosoma mansoni: migration and attrition of challenge parasites in naive rats and rats protected with vaccine serum. Parasite Immunol 1989; 11: 125-146.
18. Ho YH. On the host specificity of Schistosoma japonicum. Chin Med J (Engl) 1963; 82: 405-414.
19. Usawattanakul W, Kamijo T, Kojima S. Comparison of recovery of schistosomula of Schistosoma japonicum from lungs of mice and rats. J Parasitol 1982; 68: 783-790.
20. Moloney NA, Hinchcliffe P, Webbe G. Passive transfer of resistance to mice with sera from rabbits, rats or mice vaccinated with ultraviolet-Attenuated cercariae of Schistosoma japonicum. Parasitology 1987; 94 (Pt 3): 497-508.
21. Capron A, Dessaint JP. Effector and regulatory mechanisms in immunity to schistosomes: a heuristic view. Annu Rev Immunol 1985; 3: 455-476.
22. Davies DH, Liang X, Hernandez JE, Randall A, Hirst S, Mu Y et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci USA 2005; 102: 547-552.
23. Driguez P, Doolan D, Molina D, Loukas A, Trieu A, Felgner P et al. Protein microarrays for parasite antigen discovery In:Peacock C(ed). Parasite Genomics Protocols Vol. 1201. Springer: New York. 2015, pp 221-233.
24. Abath FG, Morais CN, Montenegro CE, Wynn TA, Montenegro SM. Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies? Trends Parasitol 2006; 22: 85-91.
25. Driguez P, Doolan DL, Loukas A, Felgner PL, McManus DP. Schistosomiasis vaccine discovery using immunomics. Parasit Vectors 2010; 3: 4.
26. McWilliam HEG, Driguez P, Piedrafita D, Maupin KA, Haab BB, McManus DP et al. The developing schistosome worms elicit distinct immune responses in different tissue regions. Immunol Cell Biol 2013; 91: 477-485.
27. McWilliam H, Driguez P, Piedrafita D, McManus D, Meeusen E. Discovery of novel Schistosoma japonicum antigens using a targeted protein microarray approach. Parasit Vectors 2014; 7: 290.
28. Wilson RA, Coulson PS. Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour. Trends Parasitol 2009; 25: 423-431.
29. Cetre-Sossah CB, Montesano MA, Freeman GL, Willard MT, Colley DG, Secor WE. Early responses associated with chronic pathology in murine schistosomiasis. Parasite Immunol 2007; 29: 241-249.
30. Rutitzky LI, Stadecker MJ. Exacerbated egg-induced immunopathology in murine Schistosoma mansoni infection is primarily mediated by IL-17 and restrained by IFN-gamma. Eur J Immunol 2011; 41: 2677-2687.
31. Fairfax K, Nascimento M, Huang SC, Everts B, Pearce EJ. Th2 responses in schistosomiasis. Semin Immunopathol 2012; 34: 863-871.
32. Gaze S, Driguez P, Pearson MS, Mendes T, Doolan DL, Trieu A et al. An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas. PLoS Pathog 2014; 10: e1004033.
33. Liu F, Lu J, Hu W, Wang SY, Cui SJ, Chi M et al. New perspectives on host-parasite interplay by comparative transcriptomic and proteomic analyses of Schistosoma japonicum. PLoS Pathog 2006; 2: e29.
34. Francis P, Bickle Q. Cloning of a 21.7-kDa vaccine-dominant antigen gene of Schistosoma mansoni reveals an EF hand-like motif. Mol Biochem Parasitol 1992; 50: 215-224.
35. Yu CX, Zhu YC, Yin XR, Ren JG, Si J, Xu YL et al. [Protective immunity induced by the nucleic acid vaccine of SjC 21.7 in mice]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2002; 20: 201-204.
36. Li Y, Auliff A, Jones MK, Yi X, McManus DP. Immunogenicity and immunolocalization of the 22.6 kDa antigen of Schistosoma japonicum. Parasite Immunol 2000; 22: 415-424.
37. Waine GJ, Becker MM, Scott JC, Kalinna BH, Yang W, McManus DP. Purification of a recombinant Schistosoma japonicum antigen homologous to the 22-kDa membraneassociated antigen of S. mansoni, a putative vaccine candidate against schistosomiasis. Gene 1994; 142: 259-263.
38. Hoffmann KF, Strand M. Molecular identification of a Schistosoma mansoni tegumental protein with similarity to cytoplasmic dynein light chains. J Biol Chem 1996; 271: 26117-26123.
39. Zhang LH, McManus DP, Sunderland P, Lu XM, Ye JJ, Loukas A et al. The cellular distribution and stage-specific expression of two dynein light chains from the human blood fluke Schistosoma japonicum. Int J Biochem Cell Biol 2005; 37: 1511-1524.
40. Stein LD, David JR. Cloning of a developmentally regulated tegument antigen of Schistosoma mansoni. Mol Biochem Parasitol 1986; 20: 253-264.
41. Jeffs SA, Hagan P, Allen R, Correa-Oliveira R, Smithers SR, Simpson AJ. Molecular cloning and characterisation of the 22-kilodalton adult Schistosoma mansoni antigen recognised by antibodies from mice protectively vaccinated with isolated tegumental surface membranes. Mol Biochem Parasitol 1991; 46: 159-167.
42. Fitzsimmons CM, Jones FM, Stearn A, Chalmers IW, Hoffmann KF, Wawrzyniak J et al. The Schistosoma mansoni tegumental-Allergen-like (TAL) protein family: influence of developmental expression on human IgE responses. PLoS Negl Trop Dis 2012; 6: e1593.
43. Liu SX, Song GC, Xu YX, Yang W, McManus DP. Anti-fecundity immunity induced in pigs vaccinated with recombinant Schistosoma japonicum 26kDa glutathione-Stransferase. Parasite Immunol 1995; 17: 355-40.
44. Yan Y, Liu S, Song G, Xu Y, Dissous C. Characterization of a novel vaccine candidate and serine proteinase inhibitor from Schistosoma japonicum (Sj serpin). Vet Parasitol 2005; 131: 53-60.
45. Molehin A, Gobert G, Driguez P, McManus D. Characterisation of a secretory serine protease inhibitor (SjB6) from Schistosoma japonicum. Parasit Vectors 2014; 7: 330.
46. Abouel-Nour MF, Lotfy M, Attallah AM, Doughty BL. Schistosoma mansoni major egg antigen Smp40: molecular modeling and potential immunoreactivity for anti-pathology vaccine development. Mem Inst Oswaldo Cruz 2006; 101: 365-372.
47. Zhou XH, Wu JY, Huang XQ, Kunnon SP, Zhu XQ, Chen XG. Identification and characterization of Schistosoma japonicum Sjp40, a potential antigen candidate for the early diagnosis of schistosomiasis. Diagn Microbiol Infect Dis 2010; 67: 337-345.
48. Al-Sherbiny M, Osman A, Barakat R, El Morshedy H, Bergquist R, Olds R. In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens. Acta Trop 2003; 88: 117-130.
49. Cook RM, Carvalho-Queiroz C, Wilding G, LoVerde PT. Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage. Infect Immun 2004; 72: 6112-6124.
50. Da'dara AA, Li YS, Xiong T, Zhou J, Williams GM, McManus DP et al. DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo. Vaccine 2008; 26: 3617-3625.
51. Fan J, Hooker CW, McManus DP, Brindley PJ. A new member of the transmembrane 4 superfamily (TM4SF) of proteins from schistosomes, expressed by larval and adult Schistosoma japonicum. Biochim Biophys Acta 1997; 1329: 18-25.
52. Da'dara AA, Faghiri Z, Krautz-Peterson G, Bhardwaj R, Skelly PJ. Schistosome Na,K-ATPase as a therapeutic target. Trans R Soc Trop Med Hyg 2012; 107: 74-82.
53. Tang XN, Ji F, Jiang YX, Zhan XD, Li CP. [Preliminary studies on protective immunity induced by recombinant protein of Schistosoma japonicum P14 gene and its mechanism against schistosome infection in mice]. Zhongguo xue xi chong bing fang zhi za zhi=Chinese journal of schistosomiasis control 2013; 25: 375-378 410.
54. Williams DL, Asahi H, Botkin DJ, Stadecker MJ. Schistosome infection stimulates host CD4(+) T helper cell and B-cell responses against a novel egg antigen, thioredoxin peroxidase. Infect Immun 2001; 69: 1134-1141.
55. Ridi RE, Tallima H. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis. Vaccine 2009; 27: 666-673.
56. El Ridi R, Tallima H. Vaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines. J Parasitol 2013; 99: 194-202.
57. He YX, Chen L, Ramaswamy K. Schistosoma mansoni, S. haematobium, and S. japonicum: early events associated with penetration and migration of schistosomula through human skin. Exp Parasitol 2002; 102: 99-108.
58. Cass CL, Johnson JR, Califf LL, Xu T, Hernandez HJ, Stadecker MJ et al. Proteomic analysis of Schistosoma mansoni egg secretions. Mol Biochem Parasitol 2007; 155: 84-93.
59. Jiang W, Hong Y, Peng J, Fu Z, Feng X, Liu J et al. Study on differences in the pathology, T cell subsets and gene expression in susceptible and non-susceptible hosts infected with Schistosoma japonicum. PLoS ONE 2010; 5: e13494.
60. Knopf PM, Nutman TB, Reasoner JA. Schistosoma mansoni: resistance to reinfection in the rat. Exp Parasitol 1977; 41: 74-82.
61. Peng J, Han H, Gobert GN, Hong Y, Jiang W, Wang X et al. Differential gene expression in Schistosoma japonicum schistosomula from Wistar rats and BALB/c mice. Parasit Vectors 2011; 4: 155.
62. Wilson RA, Langermans JA, van Dam GJ, Vervenne RA, Hall SL, Borges WC et al. Elimination of Schistosoma mansoni Adult Worms by Rhesus Macaques: Basis for a Therapeutic Vaccine PLoS Negl Trop Dis 2008; 2: e290.
63. Balic A, Bowles VM, Liu YS, Meeusen ENT. Local immune responses in sensitized sheep following challenge infection with Teladorsagia circumcincta. Parasite Immunol 2003; 25: 375-381.
64. Jungersen G, Eriksen L, Nansen P, Lind P, Rasmussen T, Meeusen ENT. Regional immune responses with stage-specific antigen recognition profiles develop in lymph nodes of pigs following Ascaris suum larval migration. Parasite Immunol 2001; 23: 185-194.
65. Bowles VM, Brandon MR, Meeusen E. Characterization of local antibody responses to the gastrointestinal parasite Haemonchus contortus. Immunology 1995; 84: 669-674.
66. Bickle QD. Radiation-Attenuated schistosome vaccination-A brief historical perspective. Parasitology 2009; 136: 1621-1632.
67. He YX, Salafsky B, Ramaswamy K. Comparison of skin invasion among three major species of Schistosoma. Trends Parasitol 2005; 21: 201-203.
68. Mountford AP, Trottein F. Schistosomes in the skin: a balance between immune priming and regulation. Trends Parasitol 2004; 20: 221-226.
69. Turner JD, Meurs L, Dool P, Bourke CD, Mbow M, Diéye TN et al. Schistosome infection is associated with enhanced whole-blood IL-10 secretion in response to cercarial excretory/secretory products. Parasite Immunol 2013; 35: 147-156.
70. Fitzsimmons CM, McBeath R, Joseph S, Jones FM, Walter K, Hoffmann KF et al. Factors affecting human IgE and IgG responses to allergen-like Schistosoma mansoni antigens: Molecular structure and patterns of in vivo exposure. Int Arch Allergy Immunol 2007; 142: 40-50.
71. Hafalla JC, Alamares JG 2nd, Acosta LP, Dunne DW, Ramirez BL, Santiago ML. Molecular identification of a 21.7 kDa Schistosoma japonicum antigen as a target of the human IgE response. Mol Biochem Parasitol 1999; 98: 157-161.
72. Pinot de Moira A, Jones FM, Wilson S, Tukahebwa E, Fitzsimmons CM, Mwatha JK et al. Effects of treatment on IgE responses against parasite allergen-like proteins and immunity to reinfection in childhood schistosome and hookworm coinfections. Infect Immun 2013; 81: 23-32.
73. Santiago ML, Hafalla JC, Kurtis JD, Aligui GL, Wiest PM, Olveda RM et al. Identification of the Schistosoma japonicum 22.6-kDa antigen as a major target of the human IgE response: similarity of IgE-binding epitopes to allergen peptides. Int Arch Allergy Immunol 1998; 117: 94-104.
74. Gobert GN, Moertel L, Brindley PJ, McManus DP. Developmental gene expression profiles of the human pathogen Schistosoma japonicum. BMC Genomics 2009; 10: 128.
75. Guo J, Li Y, Gray D, Ning A, Hu G, Chen H et al. A drug-based intervention study on the importance of buffaloes for human Schistosoma japonicum infection around Poyang Lake, People's Republic of China. Am J Trop Med Hyg 2006; 74: 335-341.
76. Gordon CA, Acosta LP, Gray DJ, Olveda RM, Jarilla B, Gobert GN et al. High prevalence of Schistosoma japonicum infection in Carabao from Samar Province, the Philippines: implications for transmission and control. PLoS Negl Trop Dis 2012; 6: e1778.
77. You H, Gobert GN, Duke MG, Zhang W, Li Y, Jones MK et al. The insulin receptor is a transmission blocking veterinary vaccine target for zoonotic Schistosoma japonicum. Int J Parasitol 2012; 42: 801-807.
78. McManus DP, Wong JY, Zhou J, Cai C, Zeng Q, Smyth D et al. Recombinant paramyosin (rec-Sj-97) tested for immunogenicity and vaccine efficacy against Schistosoma japonicum in mice and water buffaloes. Vaccine 2001; 20: 870-878.
79. Cheever AW. Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues. Bull World Health Organ 1968; 39: 328-331.
80. Liu F, Zhou Y, Wang ZQ, Lu G, Zheng H, Brindley PJ et al. The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature 2009; 460: 345-351.
81. Berriman M, Haas BJ, LoVerde PT, Wilson RA, Dillon GP, Cerqueira GC et al. The genome of the blood fluke Schistosoma mansoni. Nature 2009; 460: 352-358.
82. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics (Oxford, England) 2002; 18 (Suppl 1): S96-104.
83. Liang L, Juarez S, Nga TV, Dunstan S, Nakajima-Sasaki R, Davies DH et al. Immune profiling with a Salmonella Typhi antigen microarray identifies new diagnostic biomarkers of human typhoid. Sci Rep 2013; 3: 1043.
84. Kayala MA, Baldi P. Cyber-T web server: differential analysis of high-throughput data. Nucleic Acids Res 2012; 40: W553-W559.
85. Trieu A, Kayala MA, Burk C, Molina DM, Freilich DA, Richie TL et al. Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. Mol Cell Proteomics 2011; 10: M111 007948.
86. Huber W, Scholtens Y, Hahne F, von Haydebreck A. Differential expression. In: Bioconductor Case Studies. Springer: New York, 2008, pp 89-102.
87. Zhang M, Hong Y, Han Y, Han H, Peng J, Qiu C et al. Proteomic Analysis of Tegument-Exposed Proteins of Female and Male Schistosoma japonicum Worms. Journal of Proteome Research. 2013; 12: 5260-5270.
88. Hofmann A, Osman A, Leow CY, Driguez P, McManus DP, Jones MK. Parasite annexins-new molecules with potential for drug and vaccine development. Bioessays. 2010; 32: 967-976.